Skip to content

To decrease the side effects of spinal anaesthesia using different doses of drugs in Caesarean section

Comparitive study of fixed dose versus height adjusted dose of heavy bupivacaine in spinal anaesthesia for elective caesarean section

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041776
Enrollment
60
Registered
2022-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 1- Obstetrics Health Condition 3: 1- Obstetrics

Interventions

Intervention1: Height based group: Patients to recieve height adjusted dose(0.06mg/cm) of 0.5% heavy bupivacaine intrathecally via spinal needle at the time of induction before caesarean section Contr

Sponsors

Rajendra Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient consent 2.Age group - 21years to 40years scheduled for elective caesarean section 3.singleton pregnancy 4.Weight -40 to 80 kg 5.Height- 140cm-170cm 5.ASA II

Exclusion criteria

Exclusion criteria: 1.patient refusal 2.patient with contraindication to spinal anaesthesia 3.patient with cardiovascular disease,pre eclampsia,eclampsia and systolic BP 4.Women with fetal abnormalities 5.women with placental abnormalities

Design outcomes

Primary

MeasureTime frame
1.Incidence of maternal hypotension 2.Time to reach T8 sensory level 3.Maximum sensory level achieved and time to reach the same 4.Time taken for 2 segment sensory regression 5.Time to achieve modified bromage score 3 Timepoint: 24 hrs

Secondary

MeasureTime frame
1.Total dose of mephentermine consumption 2.APGAR score at 1 and 5 min 3.To study side effects such as nausea, vomiting ,headacheTimepoint: 24 hrs

Countries

India

Contacts

Public ContactDr Ekramul Haque

RIMS,Ranchi

ekramrims@yahoo.co.in8210696628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026